DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
80.27
-1.35 (-1.65%)
At close: May 5, 2025, 4:00 PM
80.00
-0.27 (-0.34%)
Pre-market: May 6, 2025, 4:22 AM EDT
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$402,718
Profits / Employee
$51,961
Market Cap
31.47B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,300 | 700 | 7.29% |
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
DXCM News
- 1 day ago - DexCom: Growth Is Reaccelerating But Don't Ignore The Risks - Seeking Alpha
- 3 days ago - Nasdaq Index: Dexcom, Meta, ON Semi Lead US Stocks Rebound on Trade Optimism - FXEmpire
- 3 days ago - Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring. - Barrons
- 4 days ago - DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Dexcom beats quarterly sales estimates, reiterates annual forecast - Reuters
- 4 days ago - Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program - Business Wire
- 5 days ago - Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom - CNBC
- 19 days ago - Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs - CNBC